Breaking News Instant updates and real-time market news.

APTO

Aptose Biosciences

$2.77

0.3941 (16.57%)

07:16
10/13/16
10/13
07:16
10/13/16
07:16

Aptose says FDA needs more information to remove APTO-253 clinical hold

Aptose Biosciences announced that it received a response from the FDA regarding the clinical hold of Aptose's Phase 1b clinical trial of APTO-253 in patients with hematologic cancers requesting additional information and informing Aptose that the hold would not be removed until this information is submitted and reviewed. The FDA response to Aptose focused exclusively on the request to provide the FDA with complete Chemistry, Manufacturing and Control information on the final GMP drug substance and drug product intended for the clinic.

APTO Aptose Biosciences
$2.77

0.3941 (16.57%)

09/13/16
ROTH
09/13/16
NO CHANGE
Target $8
ROTH
Buy
Clinical hold on Aptose Biosciences drug soon to be removed, says Roth Capital
Roth Capital analyst Joseph Pantginis notes that Aptose Biosciences has submitted its formal response to the FDA regarding the clinical hold on its APTO-253, which was in an ongoing Phase 1b study in hematological malignancies. The analyst sees this as an important milestone for the company and says he believes the clinical hold will be removed over the next month. He reiterates a Buy rating and $8 price target on the shares.
06/13/16
06/13/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Agios Pharmaceuticals (AGIO) upgraded to Buy from Hold at Canaccord and upgraded to Overweight from Neutral at JPMorgan with Canaccord analyst John Newman raising his price target for the shares to $90 from $50 and JPMorgan analyst Anupam Rama raising his price target for the shares to $62 from $50. 2. Estee Lauder (EL) upgraded to Buy from Outperform at CLSA after analyst Caroline Levy had a meeting with CEO Fabrizio Freda and CFO Tracey Travis and came away impressed by their confidence in Estee's business outlook, despite secular pressure on U.S. department stores and a shift in travel patterns by emerging market consumers. 3. NVIDIA (NVDA) upgraded to Buy from Neutral at Nomura with the firm saying it expects the company to benefit from strong secular trends, including higher gaming ASPs, and a strong datacenter outlook. 4. Aptose Biosciences (APTO) upgraded to Buy from Neutral at Roth Capital with analyst Joseph Pantginis saying the company has made a "significant" addition to its pipeline, signing an agreement with CrystalGenomics for CG-806, an inhibitor of Bruton's tyrosine kinase, FMS-like tyrosine kinase 3 and Aurora kinases. 5. Concho Resources (CXO) upgraded to Overweight from Equal Weight at Morgan Stanley with analysts led by Evan Calio citing a more constructive view on the long-term commodity outlook, raising long-term oil price assumption for Brent to $80 and upgraded the E&P industry view to Attractive. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
06/13/16
ROTH
06/13/16
UPGRADE
Target $8
ROTH
Buy
Aptose Biosciences upgraded to Buy at Roth Capital
As previously reported, Roth Capital analyst Joseph Pantginis upgraded Aptose Biosciences to Buy from Neutral based on an expected inflection point in the near term, namely the allowance for APTO-253 to return to the clinical. Furthermore, the analyst notes that the company has made a "significant" addition to its pipeline, signing an agreement with CrystalGenomics for CG-806, an inhibitor of Bruton's tyrosine kinase, FMS-like tyrosine kinase 3 and Aurora kinases. Pantginis expects increasing visibility for this candidate to help to drive the shares as well. The analyst raised his price target on Aptose Biosciences' shares to $8 from $4.
06/13/16
ROTH
06/13/16
UPGRADE
ROTH
Buy
Aptose Biosciences upgraded to Buy from Neutral at Roth Capital

TODAY'S FREE FLY STORIES

TSLA

Tesla

$308.03

2.43 (0.80%)

10:35
04/25/17
04/25
10:35
04/25/17
10:35
Periodicals
Union workers claim Tesla illegally intimidated them, BuzzFeed says »

The United Automobile…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    May

  • 30

    May

AEP

American Electric

$67.86

-0.11 (-0.16%)

10:35
04/25/17
04/25
10:35
04/25/17
10:35
Hot Stocks
American Electric says to invest $17.3B in capital over next three years »

American Electric Power…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 27

    Apr

10:35
04/25/17
04/25
10:35
04/25/17
10:35
General news
U.S. consumer confidence fell to a still-robust 120.3 »

U.S. consumer confidence…

FCX

Freeport McMoRan

$13.19

0.955 (7.81%)

10:34
04/25/17
04/25
10:34
04/25/17
10:34
Hot Stocks
Freeport McMoRan says near-term debt situation ins manageable »

At some point looking…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

JBLU

JetBlue

$21.75

0.22 (1.02%)

, EADSY

Airbus

$20.02

0.84 (4.38%)

10:31
04/25/17
04/25
10:31
04/25/17
10:31
Hot Stocks
JetBlue says early A321NEOs have Pratt & Whitney GTF engines »

JetBlue says "We…

JBLU

JetBlue

$21.75

0.22 (1.02%)

EADSY

Airbus

$20.02

0.84 (4.38%)

UTX

United Technologies

$117.06

0.74 (0.64%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 26

    Apr

BIIB

Biogen

$276.86

3.92 (1.44%)

10:31
04/25/17
04/25
10:31
04/25/17
10:31
Recommendations
Biogen analyst commentary  »

With Spinraza 'just…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 31

    May

UNXL

Uni-Pixel

$0.80

-0.01 (-1.23%)

10:31
04/25/17
04/25
10:31
04/25/17
10:31
Options
Uni Pixel with higher call volume »

Uni Pixel with higher…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    May

10:30
04/25/17
04/25
10:30
04/25/17
10:30
General news
The 5.8% March U.S. new home sales surge »

The 5.8% March U.S. new…

EAT

Brinker

$43.93

-1.53 (-3.37%)

10:29
04/25/17
04/25
10:29
04/25/17
10:29
Hot Stocks
Brinker says 'comfortable' with guidance provided for FY17 »

Management said on the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 03

    May

JBLU

JetBlue

$21.75

0.22 (1.02%)

10:28
04/25/17
04/25
10:28
04/25/17
10:28
Hot Stocks
Breaking Hot Stocks news story on JetBlue »

JetBlue says committed to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

JBLU

JetBlue

$21.75

0.22 (1.02%)

, ERJ

Embraer

$19.51

-0.2483 (-1.26%)

10:27
04/25/17
04/25
10:27
04/25/17
10:27
Hot Stocks
Breaking Hot Stocks news story on JetBlue, Embraer »

JetBlue says timing…

JBLU

JetBlue

$21.75

0.22 (1.02%)

ERJ

Embraer

$19.51

-0.2483 (-1.26%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

QQQ

PowerShares QQQ Trust

$134.16

1.6 (1.21%)

10:27
04/25/17
04/25
10:27
04/25/17
10:27
Technical Analysis
PowerShares QQQ Trust hits fresh 52-week highs »

The breakout that began…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FCX

Freeport McMoRan

$13.15

0.9153 (7.48%)

10:27
04/25/17
04/25
10:27
04/25/17
10:27
Hot Stocks
Breaking Hot Stocks news story on Freeport McMoRan »

Freeport says Indonesia…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

C

Citi

$60.29

0.85 (1.43%)

10:26
04/25/17
04/25
10:26
04/25/17
10:26
Hot Stocks
Citi confirms receipt of CMA license in Saudi Arabia »

The Saudi Arabian Capital…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 31

    May

  • 25

    Jul

FCX

Freeport McMoRan

$13.15

0.9153 (7.48%)

10:26
04/25/17
04/25
10:26
04/25/17
10:26
Hot Stocks
Breaking Hot Stocks news story on Freeport McMoRan »

Freeport says Indonesia…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

JBLU

JetBlue

$21.75

0.22 (1.02%)

, ERJ

Embraer

$19.51

-0.2483 (-1.26%)

10:26
04/25/17
04/25
10:26
04/25/17
10:26
Hot Stocks
JetBlue aiming for CASM ex-fuel flat to up 1% for 2018-2020 »

JetBlue (JBLU) says…

JBLU

JetBlue

$21.75

0.22 (1.02%)

ERJ

Embraer

$19.51

-0.2483 (-1.26%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

BBRY

BlackBerry

$9.29

0.21 (2.31%)

10:26
04/25/17
04/25
10:26
04/25/17
10:26
Options
BlackBerry call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LLY

Eli Lilly

$81.41

-2.01 (-2.41%)

10:26
04/25/17
04/25
10:26
04/25/17
10:26
Hot Stocks
Eli Lilly says hasn't contemplated scenario to not pursue baricitinib in RA »

On Eli Lilly's Q1…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 04

    May

  • 07

    May

  • 31

    May

10:25
04/25/17
04/25
10:25
04/25/17
10:25
General news
U.S. Richmond Fed manufacturing index dipped to 20 in April »

U.S. Richmond Fed…

FCX

Freeport McMoRan

$13.15

0.92 (7.52%)

10:24
04/25/17
04/25
10:24
04/25/17
10:24
Hot Stocks
Freeport McMoRan discussing divestments at Grasberg with Indonesia government »

Says company divestments…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

SVU

Supervalu

$4.36

0.5072 (13.17%)

10:23
04/25/17
04/25
10:23
04/25/17
10:23
Earnings
Supervalu sees FY18 revenue ex-acquisition effects to increase »

Sees FY18 adjusted EBITDA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

FCX

Freeport McMoRan

$13.10

0.865 (7.07%)

10:21
04/25/17
04/25
10:21
04/25/17
10:21
Hot Stocks
Freeport McMoRan says continuing to have discussions with Indonesia on smelters »

Comments from Q1 earnings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

EAT

Brinker

$43.77

-1.695 (-3.73%)

10:20
04/25/17
04/25
10:20
04/25/17
10:20
Hot Stocks
Brinker sees giving guidance on FY18 in August »

Brinker provides annual…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 03

    May

10:20
04/25/17
04/25
10:20
04/25/17
10:20
General news
U.S. April consumer sentiment slid 4.6 points to 120.3 in the preliminary »

U.S. April consumer…

TSN

Tyson Foods

$66.07

0.68 (1.04%)

, APFH

AdvancePierre Foods

$40.25

3.58 (9.76%)

10:19
04/25/17
04/25
10:19
04/25/17
10:19
Recommendations
Tyson Foods, AdvancePierre Foods analyst commentary  »

Tyson Foods targets are…

TSN

Tyson Foods

$66.07

0.68 (1.04%)

APFH

AdvancePierre Foods

$40.25

3.58 (9.76%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.